Status:
COMPLETED
Safety and Tolerability of ACU-4429
Lead Sponsor:
Kubota Vision Inc.
Conditions:
Healthy
Eligibility:
All Genders
55-80 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate the safety and tolerability of a new investigational drug (ACU-4429) in healthy human volunteers.
Eligibility Criteria
Inclusion
- Is male or female with age ≥ 55 and ≤ 80 years at the time of consent
- Is healthy as determined by medical history and physical examination
Exclusion
- Is receiving or has recently received treatment with a medication disallowed per the protocol
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT00703183
Start Date
May 1 2008
End Date
June 1 2009
Last Update
June 27 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Covance Clinical Research Unit, Inc
Dallas, Texas, United States, 75247